Juan Miguel Mosquera

Abstract IA33: Precision medicine at Weill Cornell Medicine/New York Presbyterian: Breaking silos, integrating resources, being inclusive

Olivier Elemento, Jeff Catalano, Gloria Cheang, 2020 .

Epigenomic alterations in localized and advanced prostate cancer.

Kyung Park, Levi A Garraway, Eugenia G. Giannopoulou, 2013, Neoplasia.

Patient derived organoids to model rare prostate cancer phenotypes

Dong Gao, Matteo Benelli, Davide Prandi, 2018, Nature Communications.

Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.

Francesca Demichelis, Eugenia G. Giannopoulou, Olivier Elemento, 2013, Cancer research.

Divergent clonal evolution of castration resistant neuroendocrine prostate cancer

Matteo Benelli, Clarisse Marotz, Davide Prandi, 2016, Nature Medicine.

Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care

Alessandro Romanel, Francesca Demichelis, Tuo Zhang, 2016, npj Genomic Medicine.

Clonal evolution of chemotherapy-resistant urothelial carcinoma

Davide Prandi, Francesca Demichelis, Olivier Elemento, 2016, Nature Genetics.

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.

Davide Prandi, Francesca Demichelis, Olivier Elemento, 2017, Cancer discovery.